Drug-induced vasculitis

Bibliography

• JENNETTE JC, FALK RJ, ANDRASSY K et al.: Nomenclature of systemic vasculitides. Arthritis Rheum. (1994) 37(2):187–192.
   PubMed Web of Science ®Google Scholar
• •Classic paper proposing the currently accepted classification scheme for the systemic vasculitides.
   Google Scholar
• JENNETTE JC, THOMAS DB, FALK RJ: Microscopic polyangiitis (microscopic polyarteritis). Semin. Diagn. Pathol (2001) 18(1):3–13.
   PubMed Web of Science ®Google Scholar
• ••Comprehensive review, which provides adetailed description of the categories of small vessel vasculitis.
   Google Scholar
• TEN HOLDER M, JOY MS, FALK RJ: Cutaneous and systemic manifestations of drug-induced vasculitis. Ann. Pharmacother. (2002) 36:130–147.
   PubMed Web of Science ®Google Scholar
• •Comprehensive review listing agents most frequently reported to cause drug-induced vasculitis.
   Google Scholar
• MERKEL PA: Drug-induced vasculitis. Rheum. Dis. Clin. North Am. (2001) 27(4):849–862.
   PubMed Web of Science ®Google Scholar
• CHOI HK, MERKEL PA, WALKER AM, NILES JM: Drug-associated antineutrophil cystoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum. (2000) 43:405–413.
   PubMed Web of Science ®Google Scholar
• ••Interesting and informative report thatsuggests that there is an association between high titres of MPO-ANCA, vasculitis, and prior use of certain medications, especially PTU and hydralazine.
   Google Scholar
• CAMBRIDGE G, WALLACE H, BERNSTEIN RM, LEAKER B: Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis. Br. J. Rheumatol (1994) 33:109–114.
   PubMedGoogle Scholar
• CHOI HK, SLOT MC, PAN G, WEISSBACH CA, NILES JL, MERKEL PA: Evaluation of antineutrophil cytoplasmic antibody seroconversion induced by minocycline, sulfasalazine, or penicillamine. Arthritis Rheum. (2000) 43:2488–2492.
   PubMed Web of Science ®Google Scholar
• SATO H, HATTORI M, FUJIEDA M et al.: High prevalence of antineutrophil cytoplasmic antibody in childhood onset Grave's disease treated with propylthiouracil. J. Clin. Endocrinol Metab. (2000) 85:4270–4273.
   PubMed Web of Science ®Google Scholar
• •More evidence of new-onset ANCA-positivity in patients treated with PTU. Authors report a high frequency of 64% positivity in 51 children treated for Graves' disease.
   Google Scholar
• SERA N, ASHIZAWA K, ANDO T et al: Treatment with propylthyouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease. Thyroid (2000) 10:595–599.
   PubMed Web of Science ®Google Scholar
• •Authors report increased frequency of ANCA in patients treated with PTU but not with methimazole. Association of positive ANCA with constitutional symptoms and agranulocytosis is reported.
   Google Scholar
• MILLER RM, SAVIGE J, NASSIS L, COMINOS BI: Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leukocytoclastic vasculitis with anti-thyroid therapy in Graves' disease. Australas. J. Dermatol (1998) 39:96–99.
   PubMedGoogle Scholar
• DOLMAN KM, GANS ROB, VERVAAT THJ et al: Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet (1993) 342:651–652.
   PubMed Web of Science ®Google Scholar
• CHASTAIN MA, RUSSO GG, BOH EE, CHASTAIN JB, FALABELLA A, MILLIKAN LE et al: Proplythiocuracil hypersensitivity: report of two patients with vasculitis and review of the literature. J. Am. Acad Dermatol (1999) 41(5):757–764.
   PubMed Web of Science ®Google Scholar
• COLAKOVSKI H: Propylthioluracil-induced perinuclear-staining antineutrophil cytoplasmic autoantibody-positive vasculitis in conjunction with pericarditis. Endocr. Pract. (2001) 7(0:37–39.
   PubMedGoogle Scholar
• HELFGOTT SM, SMITH RN: Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 21-2002. A 21-year-old man with arthritis during treatment for hyperthyroidism. N Engl. J. Med. (2002) 347:122–130.
   Google Scholar
• •Interesting case report of PTU-induced P-ANCA-positive vasculitis with cutaneous, renal and pulmonary involvement, which includes a literature review on PTU-associated vasculitis.
   Google Scholar
• MORITA S, VEDA Y, EGUCHI K Anti-thyroid drug-induced ANCA-associated vasculitis: a case report and review of the literature. Endocrinol. J. (2000) 47:467–470.
   PubMed Web of Science ®Google Scholar
• GUNTON JE, STIEL J, CLIFTON-BLIGH P, WILMSHURST E, MCELDUFF A: Prevalence of positive anti-neutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication. Euz J Endocrinol (2000) 142:587.
   PubMed Web of Science ®Google Scholar
• HERLIN T, BIRKEBAEK NH, WOLTHERS OD, HEEGAARD NH, WIIK A: Anti-neutrophil cytoplasmic autoantibody (ANCA) profiles in proplythiouracil-induced lupus-like manifestations in monozygotic triplets with hyperthyroidism. Scand. J. Rheumatol (2002) 31:46–49.
   PubMed Web of Science ®Google Scholar
• CHOI HK, MERKEL PA, TERVAERT JW, BLACK RM, MCCLUSKEY RT, NILES JL: Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis. Arthritis Rheum. (1999) 42:384–388.
   PubMed Web of Science ®Google Scholar
• PILLINGER M, STAUD R: Wegener's granulomatosis in a patient receiving propylthyiouracil for Graves' disease. Semin. Arthritis Rheum. (1998) 28:124–129.
   PubMed Web of Science ®Google Scholar
• NO AUTHORS LISTED: Case records of the Massachusetts General Hospital. Weekly clinopathological exercises.
   Google Scholar
• •• Case 30–2000. A 25-year-old man with asthma, cardiac failure, diarrhea, and weakness of the right hand. N Engl. J. Med. (2000) 343:953–961.
   Google Scholar
• GRUER P, BOLD T, VILARDO L: Case 30–2000: Churg-Strauss syndrome. N EngL J. Med. (2001) 344:858-859. Letter.
   Google Scholar
• DIETZ A, HUBNER C, ANDRASSY K [Macrolide antibiotic-induced vasculitis (Churg-Strauss syndrome)]. Laryngorhinootologic (1998) 77:111-114. German.
   Google Scholar
• LE GALL C, PHAM S, VIGNES S et al.: Inhaled corticosteroids and Churg-Strauss syndrome: a report of five cases. Bur. Resp. J. (2000) 15:978–981.
   Google Scholar
• ••Five cases of CSS are reported. All areasthmatic patients in whom systemic steroids were discontinued after steroid inhalers were administered.
   Google Scholar
• EICHENFIELD AH: Minocycline and autoimmunity. Curr. Opin. Pediatr. (1999) 11:447–4456.
   PubMedGoogle Scholar
• ••Informative review of minocycline.
   Google Scholar
• ELKAYAM O, YARON M, CASPI D: Minocycline-induced autoimmune syndromes: an overview. Semin. Arthritis Rheum. (1999) 28:392–397.
   PubMed Web of Science ®Google Scholar
• ••An extensive review of autoimmunedisorders seen with minocycline, including serological findings.
   Google Scholar
• SCHAFFER JV, DAVIDSON DM, MCNIFF JM, BOLOGNIA JL: Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris. J. Am. Acad. Dermatol. (2001) 44:198–206.
   PubMed Web of Science ®Google Scholar
• •Interesting case of cutaneous polyarteritis nodosa associated with minocycline use.
   Google Scholar
• SCHRODT BJ, KULP-SHORTEN CL, CALLEN JP: Necrotizing vasculitis of the skin and uterine cervix associated with minocycline therapy for acne vulgaris. South. Med. J. (1999) 92:502–504.
   PubMed Web of Science ®Google Scholar
• •A detailed description with biopsy findings on necrotising vasculitis induced by minocycline.
   Google Scholar
• NESHER G, ZUCKNER J: Rheumatologic complications of vitamin A and retinoids. Semin. Arthritis Rheum. (1995) 24:291–296.
   PubMed Web of Science ®Google Scholar
• CHOCHRAD D, LANGHENDRIES JP, STOLEAR JC, GODIN J: Isotretinoin-induced vasculitis imitating polyarteritis nodosa, with perinuclear antineutrophil cytoplasmic antibody in titers correlated with clinical symptoms. Rev. Rheum. Engl. Ed. (1997) 64:129–131.
   PubMedGoogle Scholar
• NICOLLS MR, TERADA LS, TUDER RM, PRINDIVILLE SA, SCHWARZ MI: Diffuse alveolar hemorrhage with underlying pulmonary capillaritis in the retinoic acid syndrome. Am. J. Respir. Crit. Care Med. (1998) 158:1302–1305.
   PubMed Web of Science ®Google Scholar
• NO AUTHORS LISTED: Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 17-1986. An 18-year-old man with cutaneous ulcers and bilateral pulmonary infiltrates. N Engl. J. Med. (1986) 314:1170–1184.
   Google Scholar
• EPSTEIN EH JR, MCNUTT NS, BEALLO R et al.: Severe vasculitis during isotretinoin therapy. Arch. Dermatol. (1987) 123:1123–1125.
   PubMed Web of Science ®Google Scholar
• VAIL T, DESCOTES J: Clinical toxicity of cytokines used as hemapoyetic growth factors. Drug Saf (1995) 13:371–406.
   PubMed Web of Science ®Google Scholar
• SCHLIESSER G, PRALLE H, LOHMEYER J: Leukocytoclastic vasculitis complicating granulocyte colony-stimulating factor (G-CSF) induced neutrophil recovery in T gamma-lymphocytosis with severe neutropenia. Ann. Hematol. (1992) 65:151–152.
   PubMed Web of Science ®Google Scholar
• JAIN RR Cutaneous vasculitis associated with granulocyte colony-stimulating factor. J. Am. Acad. Dermatol. (1994) 31:213–215.
   PubMed Web of Science ®Google Scholar
• VIDARSSON B, GEIRSSON AJ, ONUNDARSON PT: Reactivation of rheumatoid arthritis and development of leukocytoclastic vasculitis in a patient receiving granulocyte colony-stimulating factor for Felty's syndrome. Am. J. Med. (1995) 98:589–591.
   PubMed Web of Science ®Google Scholar
• FARHEY YD, HERMAN JH: Vasculitis complicating granulocyte colony stimulating factor treatment of leucopenia and infection in Felty's syndrome. J. Rheumatol. (1995) 22:1179–1182.
   PubMed Web of Science ®Google Scholar
• KELLY R, MARSDEN RA, BEVAN D: Exacerbation of psoriasis with GM-CSF therapy. Br. J. Dermatol. (1993) 128:468-469. Letter.
   Google Scholar
• DEREURE O, BESSIS D, LAVABRE-BERTRAND T et al.: Thrombotic and necrotizing panniculitis associated with recombinant human granulocyte colony-stimulating factor treatment. Br. J. Dermatol. (2000) 142:834–836.
   PubMed Web of Science ®Google Scholar
• COUDERC LJ, PHILIPPE B, FRANCK N, BALLOUL-DELCLAUX E, LESSANA-LEIBO WITCHM: Necrotizing vasculitis and exacerbation of psoriasis after granulocyte colony-stimulating factor for small cell lung carcinoma. Respir. Med. (1995) 89:237-238. Letter.
   Google Scholar
• LIOZON E, DELAIRE L, LACROIX P et al.: Raynaud's syndrome complicated by digital gangrene during treatment with interferon-al. Rev. Med. Interne (1997) 18:316-319. French.
   Google Scholar
• BACHMEYER C, FARGE D, GLUCKMAN E, MICLEA JM, ARACTINGI S: Raynaud's phenomenon and digital necrosis induced by interferon-a. Br. J. Dermatol. (1996) 135:481–483.
   PubMed Web of Science ®Google Scholar
• LINDEN D: Severe Raynaud's phenomenon associated with interferon-13 treatment for multiple sclerosis. Lancet (1998) 352:878–879.
   PubMed Web of Science ®Google Scholar
• CREUTZIG A, FREUND M, CASPARY L, ALEXANDER K: Microangiopathy in patients with chronic myelogenous leukemia treated with interferon. Microvasc. Res. (1996) 52:288–292.
   PubMed Web of Science ®Google Scholar
• CHRISTIAN MM, DIVEN DG, SANCHEZ RU, SOLOWAY RD: Injection site vasculitis in a patient receiving interferon-a for chronic hepatitis C. J. Am. Acad. Dermatol. (1997) 37:118–120.
   PubMed Web of Science ®Google Scholar
• WILSON LE, WIDMAN D, DIKMAN SH, GOREVIC PD: Autoimmune disease complicating antiviral therapy for hepatitis C virus infection. Semin. Arthritis Rheum. (2002) 32:163–173.
   PubMed Web of Science ®Google Scholar
• ••Comprehensive review of drug-induced SLEand ANCA-positive syndromes associated with interferon therapy for hepatitis C.
   Google Scholar
• ZELTSER R, VALLE L, TANCK C, HOLYST MM, RITCHLIN C, GASPARI AA: Clinical, histological and immunophenotypic characteristic of injection site reactions associated with etanercept: a recombinant tumor necrosis a receptor: Fc fusion protein. Arch. Dermatol. (2001) 137:893–899.
   PubMed Web of Science ®Google Scholar
• GALARIA NA, WERTH VP, SCHUMACHER HR Leukocytoclastic vasculitis due to etanercept therapy. J. Rheumatol. (2000) 27:2041–2044.
   PubMed Web of Science ®Google Scholar
• KERNAN WN, VISCOLI CM, BRASS LM et al.: Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl. J. Med. (2000) 343:1826–1832.
   PubMed Web of Science ®Google Scholar
• OZAWA T, SASQKI O, SOCIMACHI T, TANAKA R Primary angiitis of the central nervous system: report of two cases and review of the literature. Neurosurgery (1995) 36:173–179.
   PubMed Web of Science ®Google Scholar
• CLIFFORD-JONES RE, LOVE SS, GURUSINGHE N: Granulomatous angiitis of the central nervous system: a case with recurrent intracerebral hemorrhage. J. NeuroL Neurosurg-. Psychiatry (1985) 48:1054–1056.
   PubMed Web of Science ®Google Scholar
• FORMAN HP, LEVIN S, STEWART B, PATEL M, FEINSTEIN S: Cerebral vasculitis and hemorrhage in an adolescent taking diet pills containing phenylpropanolamine: case report and review of literature. Pediatrics (1989) 83:737–741.
   PubMed Web of Science ®Google Scholar
• MERKEL PA, KOROSHETZ WJ, IRIZARRY MC, CUDKOWICZ ME: Cocaine-associated cerebral vasculitis. Semin. Arthritis Rheum. (1995) 25(3):172–183.
   PubMed Web of Science ®Google Scholar
• •Two cases of biopsy-proven cerebral vasculitis secondary to cocaine use.
   Google Scholar
• LE HELLO C: Suspected hepatitis B vaccination-related vasculitis. J. Rheumatol. (1999) 26(1):191–194.
   PubMed Web of Science ®Google Scholar
• BUI-QUANG D, THOMAS E, RIOLS M et al.: [Cutaneous vasculitis after hepatitis B vaccination with recombinant vaccine in a renal transplant patient]. Presse Med. (1998) 27(26):1321–1323. French.
   Google Scholar
• ZAAS A, SCHEEL P, VENBRUX A, HELLMANN DB: Large artery vasculitis following recombinant hepatitis B vaccination: 2 cases. J. RheumatoL (2001) 28(5):1116–1120.
   PubMed Web of Science ®Google Scholar
• DE KEYSER F, NAEYAERT JM, HINDRYCKX P et al.: Immune-mediated pathology following hepatitis B vaccination. Two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption. Clin. Exp. RheumatoL (2000) 18(1):5.
   Google Scholar
• VANOLI M, GAMBINI D, SCORZA R A case of Churg—Strauss vasculitis after hepatitis B vaccination. Ann. Rheum. Dis. (1998) 57(4):256–257.
   PubMed Web of Science ®Google Scholar
• BERRETTA L, CARONNI M, SCORZA R Churg—Strauss vasculitis with brain involvement following hepatitis B vaccination. Clin. Exp. RheumatoL (2001) 19(0:757.
   Google Scholar
• ALLEN MB, COCKWELL P, PAGE RL: Pulmonary and cutaneous vasculitis following hepatitis B vaccination. Thorax (1993) 48(5):580–581.
   PubMed Web of Science ®Google Scholar